A Memorial Sloan-Kettering study suggests that lymphedema of the arm, a swelling that can occur following breast cancer treatment, may be reduced by acupuncture.

Memorial Sloan-Kettering is ranked as one of the best hospitals for pediatric cancer care nationally according to U.S. News & World Report.

The 60th annual Memorial Sloan-Kettering Patient Art Show drew enthusiastic crowds to view and purchase works by patients and former patients.

Two Memorial Sloan-Kettering studies that hold promise for the treatment of advanced uveal (eye) melanoma and advanced skin melanoma are making headlines at the 49th Annual Meeting of the American Society of Clinical Oncology.

In an eagerly awaited study, Memorial Sloan-Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer.

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan-Kettering.

A study has found that the majority of kidney cancer patients with small tumors have their entire kidney removed, which can increase the risk of developing chronic kidney disease and cardiovascular complications.